DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs or DNA Hypomethylating Agents in MLL-Rearranged Leukemia Cells

Bibliographic Details
Title:	DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs or DNA Hypomethylating Agents in MLL-Rearranged Leukemia Cells
Authors:	Klaus, Christine R ^, Daigle, Scott R. ^, Iwanowics, Dorothy ^, Johnston, L. Danielle ^, Therkelsen, Carly A ^, Smith, Jesse J ^, Moyer, Mikel P ^, Copeland, Robert A., Olhava, Edward J ^, Scott, Margaret Porter ^, Pollock, Roy M. ^, Raimondi, Alejandra ^*
Source:	In Blood 15 November 2013 122(21):3930-3930
Database:	ScienceDirect